One thing about this vaccine, it is developed from sample of COVID-2019 using the recombinant DNA technology. In contrast the experimental vaccine mRNA-1273 is based on Moderna’s previous effort trying to develop a vaccine for MERS-CoV. mRNA is an information molecule designed using sequence of the virus, but not by working on the COVID-2019 virus itself.BRIEF - Cansino Biologics Says Co & Institute Of Biotechnology, Academy Of Military Medical Sciences Jointly Developing Recombinant Novel Coronavirus Vaccine
March 17 (Reuters) - Cansino Biologics Inc:
* Co & Institute of Biotechnology, Academy of Military Medical Sciences jointly developing recombinant novel coronavirus vaccine
* Joint developers submitted pre-investigational new drug review application for AD5-NCOV to regulatory authorities
* Initiated preparation for clinical trials and pre-screening of volunteers Source text for Eikon: Further company coverage:
Related link: BRIEF-Cansino Biologics Says Co & Institute Of Biotechnology, Academy Of Military Medical Sciences Jointly Developing Recombinant Novel Coronavirus Vaccine
